Argos Therapeutics higher after pricing IPO below range

After pricing its 5.625M-share IPO at $8 (below a range of $13-$15), Argos Therapeutics (ARGS) opened at $8.90 and is currently at $8.69, up 9%.

The cancer/infectious disease drug developer has a market cap of $165M.

Prospectus, IPO preview

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs